Plain-English translation of NCT05819385 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to understand lung disease that develops in people with rheumatic conditions—like rheumatoid arthritis, lupus, or scleroderma—in Mexico. This is an observational study, which means researchers will review medical records and information from clinic visits over several years to see how common this lung disease is, how it changes over time, and what factors (like other health conditions or treatments) affect its course.
Lung disease is a serious complication for some people with rheumatic conditions, but we don't have enough information about how often it happens or what predicts who will have problems. By collecting information from many patients' medical records, researchers hope to better understand the patterns and causes so they can improve care and predict outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will review your medical records and information from your doctor's visits—some records from the past 10 years and some new information collected over the next few years. You may be asked to share information during clinic visits or by allowing the research team to access your existing medical records. There is no medication to take or special procedures—the study is simply about gathering and analyzing information already in your medical files to understand patterns of lung disease.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Mexico
Sponsor
Boehringer Ingelheim
Collaborators
TIC Social Mexico
Enrollment target
~312 participants
Started
June 2025
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Boehringer Ingelheim
Boehringer Ingelheim
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.